As mentioned above, the ability of GSTM2C to reduce spontaneous contractions in the neonatal cardiomyocytes suggests that it may be effective in blocking arrhythmia due to NCX activation by high cytosolic Ca2+ during diastole in both neonatal and adult heart. The gene discussed is TLX2; the disease is Arrhythmia.